Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Utilizing chromosome banding in MDS

Drorit Merkel • 6 Mar 2020
MDS 2020
Myelodysplastic Syndromes

Drorit Merkel, MD, Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel, discusses the role of chromosome banding analysis (CBA) in identifying chromosomal abnormalities in patients with MDS. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

More from Drorit Merkel

2:21
Targeted therapy for MDS
Drorit Merkel • 5 Mar 2020
1:25
Prognosis and treatment in high-risk MDS
Drorit Merkel • 5 Mar 2020
2:17
The etiology and epidemiology of myelodysplastic syndromes
Drorit Merkel • 6 Mar 2020

Related Videos

2:06
Understanding the role of inflammation and the immunome in MDS pathophysiology
Shahram Kordasti • 5 Apr 2024
2:53
Immune checkpoint inhibitors in MDS: the i4MDS consortium
Shahram Kordasti • 5 Apr 2024
2:37
Allo-SCT in older patients with MDS: selection, donors, and timing
Didier Blaise • 4 Apr 2024
1:08
Chronological age no longer dictates eligibility for allogeneic transplantation in patients with MDS
Didier Blaise • 4 Apr 2024
The content of VJHemOnc is intended for healthcare professionals